Clinical Trial: Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT04259944) titled 'Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial' on Feb. 5.

Brief Summary: PEGASUS is a prospective multi-centric study designed to prove the feasibility of using liquid biopsy to guide the post-surgical and post-adjuvant clinical management in 140 microsatellite stable Stage-III and T4N0 Stage-II colon cancer patients.

Study Type: Interventional

Condition: Colon Cancer

Intervention: * Drug: CAPOX

DAY 1

OXA 130 mg/m2 administered as intravenous infusion over 2 hours in 250 mL dextrose 5%

CAPE 1000 mg/m2 administrated per os twice daily

DAY 2-14

* CAPE ...